| Abstract |
Objective To explore the clinical effect of Nuxinto in the treatment of chronic heart failure patients, its influence on the heart function of patients before and after treatment, and its application value. Methods The number of cases in this study was 30, all from patients with chronic heart failure who were treated in our hospital from April 2020 to July 2022. All patients were blindly selected and grouped during the study period, and the observation group received Nuosinto drug treatment intervention, the control group received conventional treatment intervention. During the treatment period, the clinical effective rate (obviously effective, effective, ineffective) and cardiac function indexes (LVEDD, LVESD, LVEF) before and after treatment were counted in the two groups, and the research data were compared between groups. Results The clinical effective rate (60.00%) of the control group was significantly lower than that of the observation group (93.33%); the cardiac function indexes of the control group were {(56.883.91), (46.353.55), (37.274.64) )} was also significantly inferior to the patients in the observation group {(47.394.39), (40.443.32), (48.665.73)}, the value between groups was P<0.05, indicating that there was a comparative significance. Conclusion The clinical effect of using Nuoxinto drug treatment inter- vention in patients with chronic heart failure is very significant. This treatment measure can significantly improve the overall clinical treatment effectiveness of patients, promote the improvement of patients cardiac function indicators, and then improve the quality of life of patients. score, and comprehensively improve patients satis- faction with their nursing services.
|